Eric brings hands-on expertise in healthcare to the forefront, with a focus on prioritizing assets and commercializing therapeutics for rare diseases and orphan subsets. His past role as a McKinsey Engagement Manager uniquely positions him with extensive experience in optimizing the value of orphan and rare disease therapeutics for global bio-pharmaceutical firms. Specializing in crafting comprehensive life cycle management strategies, Eric navigates the entire spectrum from early to pivotal clinical trials, effectively expanding indications for existing products. His management style, rooted in fostering relationships, ensures the formation of cross-functional teams adept at objectively prioritizing competing development initiatives. Eric's proficiency extends to the establishment and management of Program Management Offices (PMOs), where he delivers actionable recommendations that profoundly impact organizational outcomes.